[Silicone in autoimmune diseases and cancer].
In 1992 the Food and Drug Administration (FDA) announced the restriction of silicone gel-filled breast implants until research protocol studies evaluate the relationship of silicone to connective tissue diseases, and the association of the silicone implants with breast carcinoma. Since them comprehensive epidemiologic studies have concluded that there is no connection between breast implants and the known connective tissue diseases or between the implants and breast carcinoma. During the same year, The American College of Rheumatology said that it have not been demonstrated the relationship between silicone gel breast implants and any systemic disease. Although this, the FDA restriction continues.
Elejabeitia
J
J
Departamento de Cirugía Plástica, Reparadora y Estética, Clínica Universitaria, Facultad de Medicina, Universidad de Navarra.
D001327:Autoimmune Diseases / Q000209:etiology* / Q000276:immunology; D001943:Breast Neoplasms / Q000209:etiology* / Q000276:immunology; D005260:Female; D006801:Humans; D011475:Prosthesis Failure; D020034:Silicone Gels / Q000009:adverse effects*; D014481:United States; D014486:United States Food and Drug Administration
D020034:Silicone Gels